Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)
CNY 22.31
(5.19%)
CNY 22.31
(5.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.31 Billion | 3 Billion | 2.69 Billion | 2.33 Billion | 2.15 Billion | 2.05 Billion |
| Cost of Revenue | 884.38 Million | 832.11 Million | 692.99 Million | 538.4 Million | 489.92 Million | 491.32 Million |
| Gross Profit | 2.42 Billion | 2.16 Billion | 2 Billion | 1.79 Billion | 1.66 Billion | 1.56 Billion |
| Operating Expenses | 1.77 Billion | 1.74 Billion | 1.59 Billion | 1.45 Billion | 1.31 Billion | 1.25 Billion |
| Selling, General and Administrative Expenses | 1.36 Billion | 1.48 Billion | 1.34 Billion | 1.22 Billion | 1.13 Billion | 1.08 Billion |
| Research and Development Expenses | 109.65 Million | 125.06 Million | 86.2 Million | 97.76 Million | 78.67 Million | 57.71 Million |
| Other Expenses | -22.54 Million | 130.57 Million | 162.67 Million | 133.14 Million | 102.47 Million | -11.11 Million |
| Cost and Expenses | 2.65 Billion | 2.57 Billion | 2.28 Billion | 1.99 Billion | 1.8 Billion | 1.74 Billion |
| Operating Income | 656.3 Million | 517.12 Million | 435.01 Million | 367.09 Million | 341.44 Million | 294.46 Million |
| Interest Expense | 589.4 Thousand | 774.62 Thousand | 1.5 Million | 1.1 Million | 9.96 Million | 16.26 Million |
| Income Tax Expense | 84.92 Million | 51.7 Million | 50.85 Million | 39.81 Million | 48.13 Million | 37.58 Million |
| Earnings before Tax | 653.04 Million | 517.03 Million | 413.35 Million | 364.2 Million | 341.28 Million | 283.35 Million |
| Net Income | 568.1 Million | 465.3 Million | 361.54 Million | 325.48 Million | 294.43 Million | 243.26 Million |
| Earnings Per Share Basic | 1.01 | 0.84 | 0.66 | 0.57 | 0.52 | 0.42 |
| Earnings Per Share Diluted | 1.00 | 0.82 | 0.64 | 0.57 | 0.52 | 0.41 |
| Weighted Average Shares Outstanding | 561.37 Million | 556.12 Million | 550.88 Million | 567.8 Million | 567.8 Million | 581.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 566.41 Million | 568.16 Million | 566.68 Million | 567.8 Million | 567.8 Million | 590.44 Million |
| Gross Margin | 0.73 | 0.72 | 0.74 | 0.77 | 0.77 | 0.76 |
| EBIT Margin | 0.22 | 0.20 | 0.18 | 0.20 | 0.20 | 0.18 |
| Profit Margin | 0.17 | 0.16 | 0.13 | 0.14 | 0.14 | 0.12 |
| EBITDA | 736.53 Million | 594.05 Million | 473.68 Million | 384.66 Million | 427.17 Million | 366.29 Million |
| Earnings Before Tax Margin | 0.20 | 0.17 | 0.16 | 0.16 | 0.16 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 853.1 Million | 985.38 Million | 909.04 Million | 804.69 Million | 3.31 Billion | 806.11 Million |
| Cost of Revenue | 233.07 Million | 241.56 Million | 221.83 Million | 248.34 Million | 884.38 Million | 216.28 Million |
| Gross Profit | 620.03 Million | 743.82 Million | 687.21 Million | 556.34 Million | 2.42 Billion | 589.82 Million |
| Operating Expenses | 438.64 Million | 511.29 Million | 479.77 Million | 456.18 Million | 1.81 Billion | 428.8 Million |
| Selling, General and Administrative Expenses | 558.48 Million | 486.54 Million | 449 Million | 274.64 Million | - | 465.6 Million |
| Research and Development Expenses | 27.3 Million | 24.27 Million | 20.39 Million | 43.2 Million | - | 23.16 Million |
| Other Expenses | -147.14 Million | -469.95 Thousand | -6266.90 | -2.04 Million | -3.26 Million | -223.25 Thousand |
| Cost and Expenses | 671.71 Million | 752.85 Million | 701.6 Million | 704.52 Million | 2.7 Billion | 645.09 Million |
| Operating Income | 185.96 Million | 232.53 Million | 220.82 Million | 117.21 Million | 656.3 Million | 173.61 Million |
| Interest Expense | 383.97 Thousand | 253.64 Thousand | 144.67 Thousand | -1.41 Million | -179.79 Thousand | 262.04 Thousand |
| Income Tax Expense | 25.21 Million | 35.49 Million | 30.49 Million | 13.23 Million | 84.92 Million | 24.26 Million |
| Earnings before Tax | 186 Million | 256.42 Million | 220.82 Million | 115.16 Million | 653.04 Million | 173.42 Million |
| Net Income | 160.84 Million | 222.65 Million | 190.37 Million | 101.92 Million | 568.1 Million | 149.2 Million |
| Earnings Per Share Basic | 0.28 | 0.39 | 0.34 | 0.45 | - | 0.27 |
| Earnings Per Share Diluted | 0.28 | 0.39 | 0.34 | 0.45 | - | 0.26 |
| Weighted Average Shares Outstanding | 567.99 Million | 567.99 Million | 559.93 Million | 559.72 Million | 561.37 Million | 556.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 567.99 Million | 567.99 Million | 566.6 Million | 563.73 Million | 566.41 Million | 567.3 Million |
| Gross Margin | 0.73 | 0.75 | 0.76 | 0.69 | 0.73 | 0.73 |
| EBIT Margin | 0.22 | 0.26 | 0.24 | 0.15 | - | 0.22 |
| Profit Margin | 0.19 | 0.23 | 0.21 | 0.13 | 0.17 | 0.19 |
| EBITDA | 186.39 Million | 251.58 Million | 222.45 Million | 116.75 Million | - | 174.47 Million |
| Earnings Before Tax Margin | 0.22 | 0.24 | 0.24 | 0.15 | 0.20 | 0.22 |
HWM
KDDL
CTRRF
OBDC
3537
KMP